Researchers found that sargramostim decreased UCH-L1 and total tau levels in mild-to-moderate Alzheimer’s patients. MMSE cognitive scores improved, and mouse models confirmed reduced neuronal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results